Bioequivalence Study of Two Orally Disintegrating Risperidone Formulations, Risperdal OD® Tablet 1mg and Risperdal Quicklet® Tablet 1mg in Healthy Korean Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
doi 10.12793/jkscpt.2011.19.1.31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Society for Clinical Pharmacology and Therapeutics (KAMJE)


Related search